APFED proudly supports our HOPE on the Horizon Research Grant awardees Julia Dunn, PhD, Judith A. Woodfolk, MBChB, PhD, and Ashley Pine, PhD, RDN. Thank you for your commitment to improving the lives of those living with eosinophilic disease. #HopeOnTheHorizon #EosinophilicDisease #Research #APFED

Small decisions can shape #EoE management. Watch APFED's latest webinar recording with Timothy Buckey, MD, exploring the everyday choices that influence EoE control. Now available at apfed.org/webinars and on YouTube. #EosAware

Join Michael K. Pickens, DO, FAAP, on Nov. 11 at 12 PM ET to explore the similarities and differences between EGIDs and IBD, including how clinicians approach diagnosis. Register: apfed.org/webinars #EGID

Today is DAF Day! For families like this one, your generosity means hope. Hope for answers, for relief, and for a future without fear of the next flare. Contact your fund manager or visit apfed.org/waystogive/ to send a grant to APFED today. #DAFDay #APFED #25for25

Meet two future scientists living with eosinophilic disease. Your recommended grant to APFED can help power the research that gives kids like these a healthier future. Contact your fund manager or visit apfed.org/waystogive/ and use our DAF Direct widget to send a grant to APFED today.

Do you have a Donor Advised Fund (DAF)? You can easily recommend a grant to APFED to support those living with eosinophilic diseases. Contact your fund manager or visit apfed.org/waystogive/ and use our DAF Direct widget to get started today. #DAFDay #APFED #25for25

The NIH invites those with hypereosinophilia to learn more about an investigational research study to test if dupilumab as an add-on treatment can help improve symptoms of hypereosinophilic syndrome. #HES

Registration is now open for our next webinar: Daily Decisions That Shape EoE Control October 15 at 1:00 PM ET apfed.org/events/eos-s...

Every breakthrough starts with a question. Curiosity fuels progress. What would you like to ask a researcher? Drop your question in the comments. #APFED25 #Inspire25

Behind every awareness event is someone who said, 'I want to do something.' Thank you to everyone who shows up for our community. You make a difference. 💙 Want to plan an awareness event in your community? Reach out to us at mail@apfed.org to learn how we can support you.

Eosinophilic disease awareness is taking the ice! 🏒 Join APFED on Jan. 18 at 3 p.m. for Islanders vs. Predators. A portion of ticket sales supports eosinophilic disease research—and selling all 60 tickets unlocks a High Five Line opportunity! 🎟️ apfed.org/gameon27

For 25 years, APFED has worked to connect clinicians and researchers around the shared goal of advancing eosinophilic disease understanding, and the progress speaks for itself. Help us keep the momentum going! Support continued research by donating at apfed.org/donate.

Registration is now open for APFED's next webinar about eosinophilic gastritis research. Dr. Sara Anvari will join us on September 22 to share information about understanding EoG and new research findings. Register now at apfed.org/webinars.

APFED is back with the NY Islanders for 2026–27! Catch them vs. the Predators on January 18th. 60 tickets sold = we score a group photo with the team! Let's go, Team APFED! Visit apfed.org/gameon27 to purchase your tickets today! #APFED #NYIslanders #EosinophilicDisease #GameOn27

A heartfelt thank you to the incredible speakers who made EOS Connection 2026 so meaningful. Your expertise, passion, and commitment to the eosinophilic disease community made this year's conference truly unforgettable. #Thank25 #APFED25

Caring for a child with #EoE? Check out our free webinar on July 29 at 12 PM ET. Clinicians + a patient advocate sharing real guidance for families at every stage. Supported by @PeerView and Boston University Chobanian & Avedisian School of Medicine CCE. Don't miss it! Register at apfed.org/webinars

Empower someone today. 💙 Share APFED's free webinar library — real education from trusted experts, designed for the eosinophilic disease community. Visit apfed.org/webinars. #Inspire25 #25for25 #APFED25

‼️ Encouraging news for the EG community! A new study from the Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR) found dupilumab improved outcomes for eosinophilic gastritis, an important step toward better treatments. Read more: https://ow.ly/UgfZ50ZiVVF

Dupilumab Improves Outcomes for Individuals with Eosinophilic Gastritis

A new study from the Consortium of Eosinophilic Gastrointestinal Disease Researchers shows that dupilumab improves outcomes in eosinophilic gastritis.

ow.ly

Every diagnosis given today stands on the shoulders of scientists who spent years asking the right questions. We honor the researchers and pioneers whose work first defined eosinophil-associated diseases and whose dedication made it possible for patients to finally have answers.

1 in 700 people have EoE. Most wait 4 to 6 years for a diagnosis. That has to change, and it starts with advocates like you. Download APFED's EoE Advocacy Toolkit and take action today. apfed.org/wp-content/u...

We’re encouraged to see the FDA approval of Fasenra® (benralizumab) for adults and children ages 12+ living with hypereosinophilic syndrome (HES) when the condition is not caused by another underlying non-blood-related condition. Read the announcement from AstraZeneca: https://bit.ly/493wLpr #HES

New tools to predict EGPA flares, FDA Fast Track for an eosinophilic asthma treatment, and promising EoE injection trial results — catch up in APFED's Research Round-Up apfed.org/blog/research-roundup-april-2026/

Two weeks remain to submit abstracts for the APFED 2026 Virtual Poster Hall. Researchers conducting work in eosinophil-associated diseases are encouraged to submit posters for consideration. Encore works are accepted. Submission form: apfed.org/events/annual-conference/research-posters/

Our Medical Advisory Board brings world-class expertise to everything from patient education to research priorities, ensuring that the resources we provide are accurate, current, and truly life-changing. We are deeply honored by their commitment to this community. #APFED25 #Thank25 #25for25

Every clinician who deepens their understanding of EOS conditions is a lifeline for a patient still searching for answers. 💙 Visit our CME page at: https://apfed.org/resources/for-healthcare-providers-and-researchers/conferences-and-cme-opportunities-2/

Share Your Research with the APFED Community. Abstract submissions are open for the APFED 2026 Virtual Poster Hall. Abstract deadline: May 15, 2026 Submission form: apfed.org/events/annual-conference/research-posters/

APFED's Annual Patient Conference will be held in Denver July 9–12, 2026 Registration options: → Virtual: FREE → In-person: $75 per person Learn more and register at apfed.org/conference.

Abstract submissions are now open for researchers for the Eos Connection 2026 Virtual Poster Hall. Share your research with a national audience focused on eosinophilic disorders. Submit your abstract by May 15 Full details: apfed.org/events/annual-conference/research-posters/

For people with EoE, eating is complicated. Elimination diets, symptom fear & swallowing discomfort can overlap with Avoidant/Restrictive Food Intake Disorder (ARFID). Know what to look for. apfed.org/blog

APFED is now accepting abstracts for the Virtual Poster Hall at its 2026 patient education conference. Abstract deadline: May 15, 2026 apfed.org/events/annual-conference/research-posters/